Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Virus
100%
B Cell Lines
100%
Lymphoblastoid
100%
CD4+ Cytotoxic T Cells
100%
Lymphoproliferation
66%
Dendritic Cells
66%
Ag-loaded
66%
Cancer Patients
33%
Cancer Immunotherapy
33%
High Risk
33%
Tumor-specific
33%
T Cells
33%
Adoptive Immunotherapy
33%
Peripheral Blood
33%
CD4+
33%
EBV DNA
33%
Solid Organ Transplant Recipients
33%
Memory T Cells
33%
Selective Expansion
33%
Immunocompromised Host
33%
Virus-specific
33%
EBV Serology
33%
HLA Class II
33%
EBV-negative
33%
Cell Enrichment
33%
Additional Findings
33%
CD25
33%
Specific Memory
33%
Precursor Cells
33%
Humoral Immune Response
33%
Immunology and Microbiology
Epstein Barr Virus
100%
Cytotoxic T Cell
100%
Virus
100%
CD4
100%
B-Lymphoblastoid Cell Line
13%
Lymphocyte Proliferation
9%
Dendritic Cell
9%
Antigen-Presenting Cell
9%
Precursor
4%
T Cell
4%
Adoptive Immunotherapy
4%
Immunotherapy
4%
Serology
4%
Humoral Immunity
4%
Immunocompromised Patient
4%
Memory T Cell
4%
CD25
4%
In Vitro
4%
Biochemistry, Genetics and Molecular Biology
CD4
100%
Epstein Barr Virus
100%
Cytotoxic T Cell
100%
B Cell
13%
Lymphocyte Proliferation
9%
Dendritic Cell
9%
Precursor
4%
T Cell
4%
CD25
4%
Serology
4%
Memory T Cell
4%
Humoral Immunity
4%